Combined chemotherapy regimen of carboplatin and paclitaxel as adjuvant treatment for papillary serous and clear cell endometrial cancer

International Journal of Gynecological Cancer

Volumn 19, Issue 4, 2009, Pages 662-664

  Shechter Maor, Gil ^a   Bruchim, Ilan ^a   Ben Harim, Zipi ^a   Altaras, Marco ^a   Fishman, Ami ^a  

^a MEIR MEDICAL CENTER   (Israel)

Author keywords

Carboplatin; Uterine clear cell carcinoma; Uterine papillary serous carcinoma

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ANAPHYLAXIS; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; GYNECOLOGY; HUMAN; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUTROPENIA; OBSTETRICS; PELVIS; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; THERAPY DELAY; UTERINE CLEAR CELL CARCINOMA; UTERINE PAPILLARY SEROUS CARCINOMA;

ADENOCARCINOMA, CLEAR CELL; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, PAPILLARY; CHEMOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; RETROSPECTIVE STUDIES;

EID: 67651024219     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a3d626     Document Type: Article

References (15)

1. Alobaid A, Bruchim I, Verkooijen H, et al. Adjuvant therapy for patients with stage I papillary serous endometrial cancer. Eur J Surg Oncol. 2006;32:358-362.
2. Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. Int J Gynecol Obstet. 2003;83 (suppl 1): 79-118.
3. Kelly MG, O'Malley DM, Hui P, et al. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol. 2005; 98:353-359.
4. Hendrickson M, Ross J, Eifel P, et al. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 1982;6:93-108.
5. Goff BA, Kato D, Schmidt RA, et al. Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol. 1994;54: 264-268.
6. Gehrig PA, Groben PA, Fowler WC Jr, et al. Noninvasive papillary serous carcinoma of the endometrium. Obstet Gynecol. 2001;97: 153-157.
7. Sovak MA, Hensley ML, Dupont J, et al. Paclitaxel and carboplatin in the adjuvant treatment of patients with high risk stage III and IV endometrial cancer: a retrospective study. Gynecol Oncol. 2006;103: 451-457.
8. Bozas GT, Bamias A, Kastritis E, et al. Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterus. Eur J Gynaecol Oncol. 2005;26:627-631.
9. Vaidya AP, Littell R, Krasner C, et al. Treatment of uterine papillary serous carcinoma with platinum based chemotherapy and paclitaxel. Int J Gynecol Cancer. 2006;16 (suppl 1): 267-272.
10. Randall ME, Filiaci VL, Muss H, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecology Oncology Group Study. J Clin Oncol. 2006;24:36-44.
11. Price FV, Chambers SK, Carcangiu ML, et al. Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 1993;51:383-389.
12. Levenback C, Burke TW, Silva E, et al. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecol Oncol. 1992;46:317-321.
13. Hoskins PJ, Swenerton KD, Pike JA, et al. Paclitaxel and carboplatin, alone or with irradiation, In advanced or recurrent endometrial cancer: a phase II study. J Clin Oncol. 2001;19:4048-4053.
14. Dietrich CS 3rd, Modesitt SC, Depriest PD, et al. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 2005;99:557-563.
15. Zanotti KM, Belinson JL, Kennedy AW, et al. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma. Gynecol Oncol. 1999;74:272-277.